I wrote recently about my experiences of the Pulse leadership and entrepreneurship training program for the blog of the UK BioIndustry Association (BIA). The Pulse course is organised jointly by the BIA and the Francis Crick Institute. I joined the three-day course, in its first year of operation, in 2018.
I felt that I benefited enormously from the course. I had left my postdoc position 3 months previously and I was researching ideas for setting-up a company. I subsequently took my learnings from Pulse and elsewhere, and established my first company Simmunology. So when I was contacted earlier this year I was particularly keen to write something and say thanks.
Continue reading “New article: My experience of the BIA Pulse accelerator”
Continue reading “What do I work on?”
Mathematical, statistical, AI/ML, whatever
I really love dealing with people. I come from a culture which highly prizes human interaction and communication skills. But I also love technical work, and this tends to attract people who prefer to work alone. In this article I want to discuss my progression through different styles of management and leadership throughout my life.
Continue reading “Managing People”
I wrote this article a year ago. Somehow it sat in my drafts despite being essentially finished. I publish it now as is. Any mention to what I am doing now refers to September 2019.
A short homage to Paul Graham who, among others, so nicely captured the issue of Making things vs Managing teams.
Continue reading “Maker vs Manager”
Something I’ve struggled with on and off over the 20 years that I have been making mathematical models is explaining those models to others. I have tried to bring people along and develop their understanding. But mainly what I observed was that, some people just got it and others did not.
I have certainly improved my own skill at explaining. This comes down to having streamlined stories and simpler take-home messages. Telling a clearer story certainly improves my audiences’ self-satisfaction, but ultimately some of them get the whole message and others do not.
Continue reading “Modelling the Modeller”
I had the opportunity to interview for a senior position at a very big company recently. The entire process was fascinating for what it says about human nature and about large companies. The outcome of the process is unclear at the time of writing this but I am expecting the intrinsic misalignments in the process will lead it into the reeds from which it is unlikely to emerge. I am as close to the perfect candidate for the role that they will ever interview, but the internal parties are not all aligned around the very existence of the position.
Continue reading “There is no such thing as a manager”
I had quite a nice spring season of talks planned for 2020. I was invited to deliver a keynote on AI in Healthcare at Biovaria. And, I was one of the invited speakers for the Dynamics of Immune Repertoires conference where I would also have given a workshop, in Dresden. Covid-19 struck and the rest is history.
Emergencies lead to quick changes of plans. Anthony Kelly from AI in Action reached out to me asking me to take part in a special on AI in Healthcare.
Continue reading “Talks cancelled – Talks online”
I had a very different article queued to be published today. However my server was taken offline for 10 days partly due to the Covid pandemic.
Continue reading “Covid strikes!”
I have been reconnecting with some of my academic friends. We all belong more or less to the same age cohort. In recent weeks, I have been watching them interacting with one another on Twitter and through various other media. They each have achieved considerable degrees of success in their chosen fields – all have tenure at global top-50 ranked institutions. Through my observations, I have come to the realisation that the era of the solo contributor is dead.
Continue reading “The era of the solo contributor is dead”
Working in industrial research is usually very motivating but occasionally it is also frustrating. You’ve just done something really cool but you’re not allowed to tell anybody outside the company about it. Indeed, in a small company there might not be anybody inside of the company who can even appreciate it!
I have worked on roughly 4 really cool projects since leaving academia at the end of 2017. And apart from some basic mentions in my blog (e.g. here and here) most of what I have done has been known only to a few key stakeholders.
Since leaving Fosanis last September I have had a visiting researcher affiliation at the Digital Health Accelerator of the Berlin Institute of Health. I have used my time to mentor a cohort of teams attempting to spin out their ideas; to work on a causal inference project; and, to write a paper about the structural aspects of medical AI products. This week, along with my co-author Vince Madai, we submitted that paper.
Continue reading “Preprint Announcement – AI in Medicine Product Development Framework”